These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 38303532)

  • 1. A Review on Role of Inflammation in Coronavirus Disease.
    Lotfi A; Hajian P; Abbasi L; Gargari MK; Fard NNG; Naderi D
    Endocr Metab Immune Disord Drug Targets; 2024; 24(13):1488-1505. PubMed ID: 38303532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm.
    Mahmoud IS; Jarrar YB; Febrimarsa
    Clin Exp Med; 2023 Oct; 23(6):2909-2923. PubMed ID: 37061574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
    Ahmed F
    Front Immunol; 2020; 11():590459. PubMed ID: 33362771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
    Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
    Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory pathways in COVID-19: Mechanism and therapeutic interventions.
    Jiang Y; Zhao T; Zhou X; Xiang Y; Gutierrez-Castrellon P; Ma X
    MedComm (2020); 2022 Sep; 3(3):e154. PubMed ID: 35923762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine storm induced by SARS-CoV-2.
    Song P; Li W; Xie J; Hou Y; You C
    Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible mechanisms responsible for acute coronary events in COVID-19.
    Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
    Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
    Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
    Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
    Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19.
    Wang M; Chang W; Zhang L; Zhang Y
    Int J Biol Sci; 2022; 18(15):5827-5848. PubMed ID: 36263178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation inhibitory activity of green tea, soybean, and guava extracts during Sars-Cov-2 infection through TNF protein in cytokine storm.
    Priyandoko D; Widowati W; Kusuma HSW; Afifah E; Wijayanti CR; Rizal R; Sholihah IA; Permatasari GW; Ramadhani A; Utomo DH
    Comput Biol Chem; 2023 Aug; 105():107898. PubMed ID: 37247574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.
    Rabaan AA; Al-Ahmed SH; Muhammad J; Khan A; Sule AA; Tirupathi R; Mutair AA; Alhumaid S; Al-Omari A; Dhawan M; Tiwari R; Sharun K; Mohapatra RK; Mitra S; Bilal M; Alyami SA; Emran TB; Moni MA; Dhama K
    Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs.
    Tufan A; Avanoğlu Güler A; Matucci-Cerinic M
    Turk J Med Sci; 2020 Apr; 50(SI-1):620-632. PubMed ID: 32299202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.